Strategic Acquisition WCG ThreeWire is a recently acquired, global patient recruitment specialist within the WIRB-Copernicus Group family, suggesting alignment with larger clinical research programs and potential cross-sell of site resource optimization and enrollment services to WCG's broader customer base.

Enrollment Focus The core offering centers on identifying root causes of poor enrollment and delivering customized site-level solutions, presenting opportunities to upsell enhanced enrollment analytics, patient outreach programs, and retention strategies for large and complex trials.

Mid-Sized Scale With 51-200 employees and revenue in the 50–100 million range, there is a solid mid-market footprint ideal for expanding through partnerships with mid- to large-cap sponsors and CROs seeking scalable patient recruitment without enterprise-level overhead.

Tech Enablement Existing tech stack elements such as tracking, analytics, and web tools indicate readiness for data-driven outreach, enabling sales conversations around integrated recruitment dashboards, site performance metrics, and optimization through digital channels.

Growth Potential As clinical trials grow in size and complexity, there is a clear path to expand services beyond recruitment to retention, site feasibility, and performance benchmarking, leveraging WCG ThreeWire’s proven patient-focused approach to increase trial efficiency and predictability.